Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants
Award Notice Posted
- Solicitation number
- 75A50121P00054
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Monogram Biosciences, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50121P00054 Federal contract award
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awards a contract to Monogram Biosciences, Inc. to provide laboratory assay testing capacity for evaluation of medical countermeasures against SARS-CoV-2 pseudoviruses with spike variants. The contractor will test serum samples from convalescent and vaccinated human subjects as well as therapeutic monoclonal and polyclonal antibodies to determine neutralization capabilities against predominant circulating and emerging virus variants. The fixed-price contract, valued at $10,484,700, enables rapid screening of medical countermeasures against evolving SARS-CoV-2 strains.
Notice text
The Contractor will provide laboratory assay testing capacity for evaluation of medical countermeasures for SARS-CoV-2 in a pseudovirus neutralization assay (PsVNA). The assay permits analysis of serum samples collected from human subjects (convalescent and/or vaccinated) as well as therapeutic monoclonal and polyclonal antibodies. Samples are to be tested to ascertain the ability to recognize and maintain neutralization versus both predominant circulating and emerging variants of SARS-CoV-2. The
current effort seeks to utilize a pseudotyped VN assay for rapid testing of emerging virus variants and expanded medical countermeasures (MCMs).
Awarded contract 75A50121P00054 to Monogram Biosciences, Inc. for 10487400.00 on 2021-09-20.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity